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Background. Interstitial fibrosis strongly predicts the degree and
progression of renal failure in human renal disorders. Since active
fibrosis tends to initially occur in a peritubular distribution, the
possibility that human proximal tubule cells (PTC) relay fibro-
genic signals to neighboring cortical fibroblasts was examined in
vitro.
Methods. Cell proliferation (cell counts and thymidine incorpo-
ration), total collagen synthesis (proline incorporation), matrix
metalloproteinase (MMP) activity (gelatin zymography), and au-
tocrine secretion of insulin-like growth factor-I (IGF-I) were
measured in primary cultures of human cortical fibroblasts cocul-
tured with PTC or exposed to PTC-conditioned media (PTC-
CM).
Results. Cell numbers and thymidine incorporation rates were
increased in cortical fibroblasts cocultured with PTC (136.4 6
7.3% and 119.3 6 8.2% of control values, respectively, P , 0.05)
or incubated in PTC-CM (114.0 6 5.9%, P , 0.05 and 146.7 6
13.3%, P , 0.05, respectively). PTC-CM stimulated cortical
fibroblast collagen synthesis (13.5 6 1.0% vs. 10.8 6 0.7%,
respectively, N 5 24, P , 0.05) and MMP-2 and MMP-9
secretion. Cortical fibroblast secretion of IGF-I binding protein-3
(IGFBP-3), which in turn modulates the autocrine and paracrine
actions of IGF-I, was enhanced in the presence of PTC-CM
compared with control (1162.2 6 94.2 vs. 969.1 6 58.9 ng/mg
protein/day, P , 0.05), but no change was observed in cortical
fibroblast secretion of IGFBP-2 (260.9 6 38.8 vs. 290.9 6 36.6
ng/mg protein/day, P 5 NS) or IGF-I (56.7 6 6.6 vs. 57.0 6 6.8
ng/mg protein/day, P 5 NS). Human PTC secreted transforming
growth factor-b1 (TGF-b1) and the AB heterodimer of platelet-
derived growth factor (PDGF-AB) in a time-dependent fashion
and the augmentation of cortical fibroblasts mitogenesis, collagen
synthesis and IGFBP-3 secretion induced by PTC-CM was repli-
cated by exogenous TGF-b1 and PDGF. Furthermore, the stim-
ulatory effects of PTC on cortical fibroblasts were potentiated in
transiently acidified PTC-CM (which activated latent TGF-b1),
and were abrogated by neutralizing antibodies specifically di-
rected against TGF-b1 and PDGF-AB. Cortical fibroblasts in turn
released a soluble factor(s) into cortical fibroblast-conditioned
media that reciprocally stimulated PDGF-AB production by PTC
(4.79 6 1.55 vs. 0.78 6 .06 ng/mg protein/day, P , 0.05).
Conclusions. PTC modulate the biological behavior of neigh-
boring cortical fibroblasts in the human kidney through paracrine
mechanisms, which include the production and release of
PDGF-AB and TGF-b1. Renal insults that result in proximal
tubule injury may perturb this paracrine interaction, thereby
culminating in excessive fibroblast proliferation and interstitial
fibrosis.
Clinicopathological studies have conclusively demon-
strated that tubulointerstitial rather than glomerular pa-
thology correlates with the degree and progression of renal
impairment, regardless of the type and anatomical origin of
the inciting injury [1, 2]. Based on histologic evidence that
proximal tubule cell (PTC) injury predates interstitial fi-
brosis [3] and that regions of active interstitial fibrosis
predominantly exhibit a peritubular rather than perivascu-
lar distribution [4, 5], it has been hypothesized that PTC
relay fibrogenic signals to contiguous cortical fibroblasts in
diseased kidneys. This notion is supported by an in vitro
study using rat cells that demonstrated that cortical fibro-
blasts proliferation was stimulated by unknown paracrine
signals generated by PTC in coculture [6]. It has further
been shown in this laboratory that media conditioned by
human PTC stimulate cortical fibroblast production of
insulin-like growth factor binding protein-3 (IGFBP-3),
thereby modulating the autocrine and paracrine actions of
insulin-like growth factor-I (IGF-I) [7]. Although human
PTC are known to constitutively express mRNAs for a
number of potentially fibrogenic cytokines, including trans-
forming growth factor-b (TGF-b) [8] and platelet-derived
growth factor (PDGF) [9], the role of these and other
growth factors produced by PTC and their interaction with
cortical fibroblasts has not been studied.
Thus, the aim of the present study was to determine
whether human PTC were able to modulate cortical fibro-
blasts processes relevant to tubulointerstitial pathology,
1 See Editorial by Nath, p. 992.
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including cellular growth, matrix turnover and IGF-I/
IGFBP production. The potential contributions of




Segments of macroscopically and histologically normal
renal cortex were obtained aseptically from adult human
kidneys removed surgically because of small (,6 cm) renal
adenocarcinomas (N 5 9), pelviureteric transitional cell
carcinoma (N 5 4), benign angiomyolipoma (N 5 1) or
benign renal cyst (N 5 1). The average patient age was
64.4 6 3.6 years and the male:female ratio was 9:6. Patients
were otherwise healthy and were on no medications. In-
formed consent was obtained prior to each operative
procedure, and the use of human renal tissue for primary
culture was reviewed and approved by the Royal North
Shore Hospital and University of Sydney Human Medical
Research Ethics Committee.
Cell culture
The method for primary culture of human PTC and
cortical fibroblasts is described in detail elsewhere [7, 10].
Briefly, renal cortical tissue was dissected from the medulla,
minced, digested with collagenase (class 2, 383 U/mg;
Worthington, Freehold, NJ, USA) and passed through a
100 mm mesh. Filtered tissue was resuspended in 45%
Percoll (Pharmacia, Uppsala, Sweden) and separated into
four distinct bands by isopyknic ultracentrifugation. The
lowermost band was removed for PTC culture. The upper-
most band was removed for renal cortical fibroblast culture.
Proximal tubule cells were resuspended in serum-free,
antibiotic-free, hormonally-defined media, consisting of 1:1
(vol/vol) Dulbecco’s modified Eagle’s media and Ham’s
F-12 (DMEM/F-12; ICN Pharmaceuticals Inc., Costa
Mesa, CA, USA), supplemented with 5 mg/ml human
transferrin (Sigma), 5 mg/ml (0.87 mmol/liter) bovine insu-
lin (Sigma), 0.05 mmol/liter hydrocortisone (Sigma), 10
ng/ml (1.64 nmol/liter) epidermal growth factor (Collabo-
rative Research Inc., Bedford, MA, USA), 50 mmol/liter
prostaglandin E1 (Sigma), 50 nmol/liter selenium (Sigma)
and 5 pmol/liter tri-iodothyronine (Sigma). The tubular
fragments were plated at a density of 1.5 mg pellet/cm2
(approximately 5000 fragments/cm2) in 75 cm2 flasks
(Corning, New York, USA). Media were changed every 48
hours. The cells were incubated in humidified 95% air/5%
CO2 at 37°C and were subcultured at near-confluence using
a seeding density of 4000 cells/cm2. Such cells were desig-
nated passage 1.
Cortical fibroblasts were resuspended in antibiotic-free
DMEM/F-12 supplemented with 10% fetal calf serum
(Trace Biosciences, Sydney, Australia) and were seeded at
an initial density of 2.25 mg pellet/cm2. Subculture at
confluence was subsequently performed using a seeding
density of 7000 cells/cm2. Because doubling times were
greater for cortical fibroblasts than for PTC, the higher
seeding densities used in the former group allowed the
synchronization of the attainment of confluence in both
populations at approximately five days after plating.
Cytologic examination of PTC and cortical fibroblast
preparations from all donors failed to reveal any evidence
of cellular atypia. The morphologic, biochemical and func-
tional characteristics of these cells have been previously
studied in this laboratory and found to reproducibly exhibit
the features of PTC and cortical fibroblasts in vivo [7, 10].
Specifically, PTC exhibit typical morphology along with
intact tight junctions, parathyroid hormone (but not vaso-
pressin) response, cAMP production and polarized trans-
port systems, including pharmacologically distinct apical
and basolateral sodium-hydrogen exchange (NHE), phlori-
zin-inhibitable apical Na1-glucose transport, parathyroid
hormone (PTH)-inhibitable apical Na1-phosphate trans-
port, probenecid-inhibitable vectorial organic anion trans-
port, and quinine-inhibitable vectorial organic cation trans-
port. Cortical fibroblasts also display typical ultrastructural
morphology and exhibit positive immunohistochemical
staining for vimentin and 59-ectocytonucleotidase, but neg-
ative staining for cytokeratin, a-smooth muscle actin and
desmin.
Experimental protocol
The paracrine modulation by PTC of cortical fibroblasts
was initially assessed by determining the effect of PTC-CM
and coculture on cortical fibroblast growth, collagen syn-
thesis, MMP secretion and IGF-I/IGFBP production. Fur-
ther experiments were designed to elucidate the relative
contributions of PDGF and TGF-b to these PTC-cortical
fibroblasts interactions by determining whether PTC se-
crete TGF-b and/or PDGF, whether production of these
factors was subject to feedback regulation by cortical
fibroblasts, and whether the effects of PTC-CM on cortical
fibroblasts could be reproduced by exogenous TGF-b
and/or PDGF and specifically blocked by anti-TGF-b or
anti-PDGF antibodies. The effect of enhancing PTC-de-
rived TGF-b activity by transiently acidifying PTC-CM was
also determined.
All experiments were performed on confluent, quiescent
passage 2 PTC and cortical fibroblasts. Cells were made
quiescent by three washes followed by incubation for 24
hours in basic media (DMEM/F-12 containing 5 mg/ml
human transferrin).
Conditioned media and coculture experiments
PTC- and cortical fibroblast-conditioned media were
obtained by incubating quiescent PTC and cortical fibro-
blasts, respectively, for 24 hours in 8 ml of fresh basic media
in 25 cm2 flasks. The media were then collected and
centrifuged to remove cellular material. One milliliter of
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PTC-CM was added to each cortical fibroblasts monolayer
grown in a 2 cm2 well, while the remainder was retained for
IGF-I, IGFBP-2 and IGFBP-3 measurements. Cortical
fibroblasts incubated in basic media served as controls.
Cortical fibroblasts were also exposed to cortical fibroblast-
conditioned media to ensure that the effects of PTC-CM on
cortical fibroblasts were cell-type specific. At the end of the
incubation period, media were collected for determination
of cortical fibroblasts production of MMPs, IGF-I and
IGFBPs, while cortical fibroblasts growth and collagen
synthesis assays were performed, as described below.
Coculture experiments were performed to determine
whether any growth effects exerted by PTC-derived soluble
factors on cortical fibroblasts were subject to feedback
regulation and to assess the potentially different effects of
sustained release of growth factors by coincubated cells.
Confluent monolayers of PTC grown on porous membrane
filter inserts (Millicell-CM, 0.4 mm, 12 mm diameter;
Millipore, Bedford, MA, USA) were placed over confluent
cortical fibroblasts monolayers grown in 24-well culture
plates (Nunc, Roskilde, Denmark). Both cell populations
were incubated together for 24 hours in basic media.
Cortical fibroblasts grown in 24-well plates without PTC
served as controls. Cortical fibroblast numbers, thymidine
incorporation and MMP secretion were subsequently mea-
sured.
Cortical fibroblast growth and activation studies
Growth parameters were measured according to previ-
ously described methods [11]. Twenty-four hours prior to
study, 0.15 MBq (4 mCi) of [methyl-3H]-thymidine (37
MBq/ml, 185 GBq/mmol; Amersham) was added to each
milliliter of media that was incubated with cells. At the end
of the incubation periods, cells were dislodged with 80
ml/cm2 CR-Dispase (Collaborative Research Inc., Bedford,
MA, USA) for 10 minutes at 37°C. Cells were then washed
three times in phosphate-buffered saline (PBS) at 1250 g
and 4°C for five minutes. Aliquots of the cell suspensions
were retained for cell counting in a standard hemocytom-
eter and for determination of thymidine incorporation by
liquid scintillation counting in a b-counter (1215 Rackbeta
II; LKB Wallac, Turku, Finland).
Collagen synthesis assay
Cortical fibroblast collagen synthesis was measured by
tritiated proline incorporation into collagenase-sensitive
proteins [12]. Following 24 hours of incubation in basic
media (control) or test PTC-CM, cortical fibroblasts were
washed and incubated for a further three hours under the
same conditions in the presence of 20 mCi/ml L-[2,3-3H]-
proline (45 Ci/mmol, 1.67 TBq/mmol, Amersham), 50
mg/ml l-ascorbic acid (Sigma) and 60 mg/ml b-aminopro-
prionitrile (Sigma). Media, containing secreted, non-cross-
linked collagen, were collected on ice and precipitated
overnight at 4°C with 1 ml 10% trichloroacetic acid (TCA)
containing 0.02% unlabeled proline (Sigma). Pellets ob-
tained by centrifugation at 2670 rpm (1250 g) for five
minutes were washed a further three times in 1 ml 5% TCA
and 0.01% proline and subsequently dissolved in 200 ml 0.2
mol/liter NaOH. The solution was titrated to pH 7.6 with
0.2 mol/liter HCl and 100 ml was incubated for one hour at
37°C with 400 ml Tris-CaCl2-N-ethylmaleimide buffer (50
mmol/liter Tris-HCl, 5 mmol/liter CaCl2, 2.5 mmol/liter
N-ethylmaleimide, 0.02% NaN3) in both the presence and
absence of 2 mg/ml collagenase (class II; Worthington).
The reaction was terminated by precipitation with ice-cold
10% TCA and 0.5% tannic acid (final concentrations) for
one hour at 4°C. Samples were centrifuged at 2670 rpm
(1250 g) for five minutes. Supernatants were counted in a
b-counter and results obtained from samples that were not
exposed to collagenase served as background counts. Pel-
lets derived from the collagenase group were solubilized in
200 ml 0.2 mol/liter NaOH and counted to measure proline
incorporation into collagenase-insensitive proteins. The
percent of total protein synthesized as collagen and re-
leased into media (% collagen) was calculated as the ratio
of collagenase-releasable disintegrations per minute (dpm)
divided by total dpm (supernatant plus pellet) as follows:
% collagen 5 ~C/P!/@5.4 3 ~1 2 C/P!# 1 ~C/P! 3 100
were C is the collagenase-releasable dpm in supernatants
and P is the collagenase-insensitive dpm in pellets.
A correction factor of 5.4 for non-collagen protein was
used to adjust for the relative abundance of proline and
hydroxyproline in proteins containing collagen [12].
Gelatin zymography
Zymography was used to visualize MMP activities in
serum-free media conditioned for 24 hours by cortical
fibroblasts exposed to basic media (controls), PTC-condi-
tioned media (PTC-CM) or PTC in coculture. After cen-
trifuging at 2670 rpm (1250 g) for five minutes to remove
cellular debris, media samples containing equal amounts of
protein were subjected to sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis under non-reducing
conditions through a 4% polyacrylamide stacking gel and
resolved in a 10% separating gel containing 1 mg/ml gelatin
(Sigma). Gels were run at 8 to 12 mA/gel and a constant
125 V for approximately 90 minutes at 4°C. After electro-
phoresis, the gels were incubated in 2.5% Triton X-100
(Sigma) with gentle shaking for one hour at room temper-
ature with one change of detergent solution. The gels were
rinsed in distilled water and incubated overnight at 37°C in
substrate buffer (50 mmol/liter Tris-HCl, 100 mmol/liter
NaCl, 10 mmol/liter CaCl2, 0.02% NaN3, pH 7.5). After
incubation, the gels were stained for 15 minutes in 0.2%
Coomassie blue R-250 (Bio-Rad, Hercules, CA, USA)
dissolved in 50% ethanol/10% acetic acid followed by
destaining for 15 minutes in 30% ethanol/10% acetic acid.
Johnson et al: Tubulointerstitial paracrine interaction 749
MMP activities appeared as clear lytic bands, which were
quantitated by densitometry using the Kodak electrophore-
sis documentation and analysis system (Kodak Scientific
Imaging Systems, Rochester, NY, USA).
Measurement of growth factors in conditioned media
Cortical fibroblast secretion of IGF-I into culture media
was determined by specific radioimmunoassay (RIA) fol-
lowing Bio-Spin chromatographic separation of IGFBPs, as
previously described [7]. IGFBP-3 and IGFBP-2 levels in
cortical fibroblast-conditioned media samples were mea-
sured using previously published specific RIAs [13, 14].
TGF-b1 levels in cortical fibroblast-conditioned media
and PTC-CM were measured using a commercially avail-
able enzyme-linked immunoassay (ELISA) kit (human
TGF-b1 Biotrak assay; Amersham, Buckinghamshire, UK).
Active TGF-b1 was measured in conditioned media di-
rectly, while the total (active plus latent) TGF-b1 was
determined following transient acidification of conditioned
media to a pH of 2. Each milliliter of conditioned media
was acidified with 30 ml of 1 mol/liter HCl for 10 minutes at
room temperature, followed by neutralization (to pH 7.4)
with 36 ml of 1.2 mol/liter NaOH/0.5 mol/liter HEPES.
Cross-reactivities with TGF-b2 and TGF-b3 were negligi-
ble. The minimum detectable concentration of TGF-b1 by
the assay was 4 pg/ml.
PDGF-AB was also measured in cortical fibroblast- and
PTC-CM samples by commercial ELISA kit (human
PDGF-AB Biotrak assay; Amersham). Cross-reactivities
with the AA and BB dimers of PDGF were 10% and 2%,
respectively. The minimum detectable concentration of
PDGF-AB by the assay was 8.4 pg/ml. Intra- and inter-assay
coefficients of variation for both ELISAs were less than 5%
and 10%, respectively.
Detection of cortical fibroblast feedback on proximal
tubule cell production of growth factors
PDGF-AB levels were measured in cortical fibroblast-
conditioned media added to PTC for 24 hours. PDGF-AB
was not detectable in cortical fibroblast-conditioned media
prior to exposure to PTC. Basic media conditioned by PTC
for 24 hours served as controls. Given that cortical fibro-
blasts have previously been demonstrated to influence PTC
growth and function by the production of IGF-I [7],
additional experiments were also performed to ascertain
whether PTC production of PDGF-AB and/or TGF-b1
could be stimulated by incubation with 100 ng/ml recombi-
nant human IGF-I (Kabi Peptide Hormones, Stockholm,
Sweden).
TGF-b1 production by PTC following exposure to corti-
cal fibroblast-conditioned media could not be reliably mea-
sured because baseline TGF-b1 levels in cortical fibroblast-
conditioned media were similar to those in PTC-CM.
Effects of exogenous PDGF-AB and TGF-b1 on cortical
fibroblasts
To determine whether the effects of PTC-CM could be
reproduced by exogenous cytokines, cortical fibroblasts
thymidine incorporation, collagen synthesis and production
of IGF-I and IGFBPs were evaluated following exposure
for 24 hours to basic media containing various concentra-
tions of human PDGF-AB (0.3125 to 10 ng/ml; Sigma),
human TGF-b1 (0.001 to 10 ng/ml; Sigma) or vehicle
(controls).
Immunoneutralization studies
The relative contributions of TGF-b1 and PDGF-AB to
the stimulation of cortical fibroblasts by PTC-CM were
assessed by immunoneutralization. Cortical fibroblasts
were incubated for 24 hours in basic media or PTC-CM
containing 100 mg/ml goat polyclonal anti-PDGF-AB anti-
body (anti-PDGF; Upstate Biotechnology Incorporated,
Lake Placid, NY, USA), 100 mg/ml goat non-immune
globulin (GNIG; Sigma), 30 mg/ml mouse monoclonal
anti-TGF-b1, -b2, -b3 antibody (anti-TGF-b; Genzyme,
Cambridge, MA, USA) or 30 mg/ml mouse non-immune
globulin (MNIG; Sigma). Cortical fibroblasts numbers,
thymidine incorporation, collagen synthesis, MMP secre-
tion and production of IGF-I and IGFBPs were then
evaluated. Antibody concentrations used in the above
experiments were based on the results of pilot studies,
which demonstrated that 30 mg/ml anti-TGF-b abrogated
the proliferative response of cortical fibroblasts to 1 ng/ml
TGF-b1, while 100 mg/ml anti-PDGF inhibited the mito-
genic effects of 10 ng/ml PDGF-AB (data not shown).
Transient acidification of proximal tubule cell-
conditioned media
The contribution of TGF-b1 to the effects of PTC-CM on
cortical fibroblasts were further assessed by transiently
acidifying media samples to a pH of 2, as described above,
to activate latent TGF-b1. cortical fibroblasts were incu-
bated with transiently acidified basic media (control) or
PTC-CM for 24 hours. Thymidine incorporation, collagen
synthesis and IGF-I/IGFBP production were subsequently
evaluated.
Statistical analysis
All studies were performed in triplicate from PTC and
cortical fibroblasts cultures obtained from 4 to 12 separate
human donors. Normal distribution of all data were con-
firmed by the Kolmogorov-Smirnov test. Results are ex-
pressed as mean 6 SEM or as median (interquartile range),
depending on the distribution of data. Statistical differ-
ences between groups were assessed by Student’s t-test,
Mann-Whitney U-test, one-way analysis of variance
(ANOVA) or Kruskal Wallis test, depending on the data
distribution and the number of comparisons being made.
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Pairwise multiple comparisons for significant ANOVAs
were made by Fisher’s protected least significant differ-
ences test. Analyses were performed using the software
package, Statview version 4.5 (Abacus Concepts Inc.,
Berkeley, CA, USA). P values less than 0.05 were consid-
ered significant.
RESULTS
Proximal tubule cells stimulate cortical fibroblasts
growth, collagen synthesis, MMP-2 and MMP-9
secretion, and IGFBP-3 production
PTC-CM, but not cortical fibroblast-conditioned media,
significantly stimulated cortical fibroblast proliferation and
DNA synthesis (Fig. 1). Coculture of PTC with cortical
fibroblasts also promoted increased cell numbers and thy-
midine incorporation, although the effect on the former
was more pronounced than with PTC-CM (Fig. 1).
PTC-CM significantly stimulated cortical fibroblasts col-
lagen synthesis and secretion into media compared with
control conditions (13.5 6 1.0% vs. 10.8 6 0.7%, respec-
tively, N 5 24, P , 0.05).
Zymography of media conditioned by cortical fibroblasts
under control conditions demonstrated gelatinolytic bands
at 92 and 72 kD, corresponding to MMP-9 (gelatinase B)
and MMP-2 (gelatinase A), respectively (Fig. 2). Exposure
of cortical fibroblasts to PTC-CM or to cocultured PTC
resulted in marked increases in the intensities of both
bands. A similar finding was observed for PTC exposed to
cortical fibroblast-conditioned media. Moreover, in approx-
imately half of the number of gels studied, an additional 88
kD band, consistent with an activated form of MMP-9,
could be resolved in cortical fibroblasts exposed to
PTC-CM or PTC in coculture. In the coculture studies, this
activation was only apparent in basolateral compartment
media, which lay in contact with both cell populations.
IGFBP-3 secretion was also significantly increased in
cortical fibroblasts incubated with PTC-CM compared with
controls (1162.2 6 94.2 vs. 969.1 6 58.9 ng/mg protein/day,
respectively, N 5 30, P , 0.05). However, no change was
observed in the production of either IGF-I (56.7 6 6.6 vs.
57.0 6 6.8 ng/mg protein/day, N 5 30) or IGFBP-2
(260.9 6 38.8 vs. 290.9 6 36.6 ng/mg protein/day, N 5 30,
respectively).
Proximal tubule cells secrete TGF-b1 and PDGF-AB
peptides
Proximal tubule cells secreted total TGF-b1 in a time-
dependent fashion (Fig. 3). After 24 hours, average pro-
duction of total TGF-b1 was 1.66 6 0.03 ng/mg protein
(N 5 30), resulting in a concentration of 51.5 6 0.23 pg/ml
in conditioned media samples. Secretion of active TGF-b1,
measured directly in PTC-CM samples without prior acid
activation, was undetectable in approximately two thirds of
samples and averaged 0.85 6 0.05 ng/mg protein/day in the
remaining one third. Cortical fibroblasts were also found to
produce 1.16 6 0.10 ng total TGF-b1/mg protein/day.
However, active TGF-b1 was undetectable in all cortical
fibroblast-conditioned media samples. Because of these
results, subsequent assays were restricted to the measure-
ment of total TGF-b1.
PTC secreted PDGF-AB at a rate of 1.02 6 0.13 ng/mg
protein/day (Fig. 3). However, PDGF-AB was not detected
in cortical fibroblast-conditioned media.
Cortical fibroblasts regulate secretion of PDGF-AB by
proximal tubule cells
Proximal tubule cells exposed to cortical fibroblast-
conditioned media secreted significantly greater quantities
of PDGF-AB compared with controls (4.79 6 1.55 vs.
0.78 6 0.06 ng/mg protein/day, respectively, N 5 9, P 5
0.02). PTC exposed to 100 ng/ml IGF-I (Kabi Peptide
Hormones, Stockholm, Sweden) also produced increased
amounts of PDGF-AB compared with vehicle (1.45 6 0.29
vs. 0.78 6 0.06 ng/mg/day, respectively, N 5 9, P , 0.05).
Exogenous TGF-b1 and PDGF-AB replicate the effects of
PTC-CM on cortical fibroblasts
Exogenous TGF-b1 and PDGF-AB significantly in-
creased cortical fibroblasts thymidine incorporation to
maximum amounts of 158.1 6 16.1% and 142.1 6 16.5% of
control values, respectively (Figs. 4 and 5). The lowest
concentrations at which significant stimulation occurred
were 10 pg/ml and 5 ng/ml, respectively.
IGFBP-3 secretion was also significantly stimulated by
TGF-b1 and, to a lesser extent, by PDGF (Figs. 4 and 5).
Fig. 1. Paracrine effects of proximal tubule cells (PTC) on cortical
fibroblasts growth. Confluent, quiescent cortical fibroblasts monolayers
were incubated for 24 hours in PTC conditioned media (CM; f), cortical
fibroblast-conditioned media (M) or media shared with cocultured PTC
(o; N 5 36). Cell density and thymidine incorporation were then
measured and normalized against controls (cortical fibroblasts incubated
in basic media). *P , 0.05 versus controls.
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One hundred pg/ml TGF-b1 and 5 ng/ml PDGF produced
increases in the IGFBP-3 release similar to that produced
by PTC-CM. Moreover, the magnitude of the increase in
IGFBP-3 secretion in response to exogenous TGF-b1 was
constant over time (Fig. 6). In contrast to IGFBP-3,
IGFBP-2 secretion was not significantly altered by either
TGF-b1 (495.3 6 90.5 ng/mg protein/day) or PDGF-AB
(521.2 6 107.0 ng/mg protein/day) relative to control
conditions (544.5 6 87.6 ng/mg protein/day).
However, IGF-I production by cortical fibroblasts was
significantly augmented by 1 ng/ml TGF-b1 (75.8 6 5.6 vs.
56.7 6 6.6 ng/mg protein/day, N 5 12, P , 0.05). On the
other hand, exposure of cortical fibroblasts to 5 ng/ml
PDGF resulted in an insignificant decrease in IGF-I syn-
thesis compared with controls (24.9 6 2.7 vs. 20.8 6 2.5
ng/mg protein/day, N 5 12, P 5 NS).
Anti-transforming growth factor-b and anti-PDGF
antibodies antagonize the effects of PTC-CM on cortical
fibroblasts
Immunoneutralization studies were performed to exam-
ine the potential roles of TGF-b1 and PDGF-AB in the
mitogenic, collagen synthetic and IGFBP-3 secretory re-
sponses of cortical fibroblasts to PTC-CM. Anti-TGF-b
antibody (30 mg/ml) and anti-PDGF antibody (100 mg/ml)
Fig. 2. Typical gelatin substrate zymograph showing the effect of conditioned media (CM) exposure or coculture on matrix metalloproteinase (MMP)
secretion and activity. Media containing equal amounts of protein were loaded in each lane. Confluent, quiescent cells were incubated in basic media
(control), CM or coculture for 24 hours. Lane 1, cortical fibroblasts control. Lanes 2, 6, 8 and 10, proximal tubule cell (PTC) controls. Lane 3, cortical
fibroblasts incubated in PTC-CM. Lane 4, PTC incubated in cortical fibroblast-conditioned media. Lanes 5, 7 and 9, cortical fibroblast and PTC
coculture. For coculture studies, media was collected from both apical and basolateral compartments (lanes 5 and 6), basolateral compartment only
(lanes 7 and 8) or apical compartment only (lanes 9 and 10).
Fig. 3. Time-dependent secretion of TGF-b1 (E) and PDGF-AB (f) by
PTC. TGF-b1 and PDGF-AB levels were measured by ELISA in media
conditioned by confluent, quiescent PTC monolayers for various time
periods, as indicated. Results were adjusted for cellular protein content.
Error bars less than the diameters of the symbols are not shown.
Fig. 4. Concentration-dependent effects of TGF-b1 on cortical fibroblast
DNA synthesis and IGFBP-3 secretion. Confluent cortical fibroblasts
monolayers were incubated in various concentrations of TGF-b1 for 24
hours. DNA synthesis and IGFBP-3 secretion into conditioned media
were measured by thymidine incorporation and specific radioimmunoas-
say, respectively. Results are normalized against control conditions (cor-
tical fibroblasts incubated in basic media containing TGF-b1 vehicle).
Symbols are: (f) thymidine incorporation; (M) IGFBP-3 secretion; *P ,
0.05 versus control.
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had no significant effect on basal cortical fibroblasts thymi-
dine incorporation (94.3 6 15.0% and 101.5 6 14.3% of
control values, respectively, P 5 NS), but each significantly
blocked the mitogenic response to PTC-CM (Fig. 7). The
combination of the two antibodies in PTC-CM resulted in
a slightly lower thymidine incorporation (87.3 6 9.5%)
compared with controls, but the difference did not achieve
statistical significance.
Stimulation of cortical fibroblasts collagen synthesis by
PTC-CM (129.4 6 6.0% of control values, P , 0.05) was
also significantly and nearly totally blocked in the presence
of either anti-TGF-b (104.9 6 10.7% of controls) or
anti-PDGF (107.1 6 6.4% of controls; Fig. 7). However,
anti-TGF-b and anti-PDGF had no significant effects on
basal proline incorporation (95.7 6 9.2% and 95.7 6 9.2%
of control values, respectively).
The effects of the antibodies on MMP secretion were
variable, but generally did not significantly attenuate the
stimulatory effects of PTC on cortical fibroblasts. For
MMP-9 secretion, median (interquartile range) band inten-
sities for cortical fibroblasts incubated with anti-PDGF
antibody, anti-TGF-b antibody, cocultured PTC, cocul-
tured PTC and anti-PDGF antibody, and cocultured PTC
and anti-TGF-b antibody were 73.1% (91.6%), 55.5%
(77.1%), 213.6% (83.3%), 170.2% (40.9%) and 162.5%
(101.0%) of control values, respectively (N 5 4, P 5 NS).
Corresponding values for MMP-2 secretion were 130.4%
(114.4%), 63.2% (76.5%), 229.2% (239%), 251.4%
(231.5%) and 94.3% (205.1%) (P 5 0.1). The antibodies
did not exert any significant effects on MMP secretion by
cortical fibroblasts under basal conditions.
Stimulation of cortical fibroblasts IGFBP-3 secretion by
PTC-CM was partially, but significantly antagonized by
anti-TGF-b and anti-PDGF antibodies compared with the
effects of MNIG and GNIG, respectively (Fig. 7). In all
studies, GNIG and MNIG did not appreciably alter the
stimulatory effects of PTC-CM on cortical fibroblasts.
Transient acidification enhances the effects of PTC-CM
on cortical fibroblasts
Cortical fibroblasts exposed to transiently acidified
PTC-CM exhibited a significant increase in collagen syn-
thesis (158.7 6 20.0% of control) and IGFBP-3 secretion
(153.62 6 4.33% of control) compared with cortical fibro-
blasts incubated with non-acidified PTC-CM (116.7 6 5.0%
and 137.77 6 4.42% of control values, respectively, N 5 12,
P , 0.05; Fig. 8). Cortical fibroblast thymidine incorpora-
tion increased numerically, but not significantly, in the
presence of transiently acidified PTC-CM compared with
non-acidified PTC-CM.
DISCUSSION
In the present study, human proximal tubule cells (PTC)
were found in both coculture and conditioned media (CM)
experiments to be capable of stimulating cortical fibroblast
(CF) proliferation, collagen synthesis and IGFBP-3 secre-
tion via paracrine mechanisms which involved both
PDGF-AB and TGF-b1. A further novel finding was that
Fig. 5. Concentration-dependent effects of PDGF on cortical fibroblasts
DNA synthesis and IGFBP-3 secretion. Confluent cortical fibroblasts
monolayers were incubated in various concentrations of PDGF for 24
hours. DNA synthesis and IGFBP-3 secretion into conditioned media
were measured by thymidine incorporation and specific radioimmunoas-
say, respectively. Results are normalized against control conditions (cor-
tical fibroblasts incubated in basic media containing TGF-b1 vehicle).
Symbols are: (f) thymidine incorporation; (M) IGFBP-3 secretion; * P ,
0.05 versus control.
Fig. 6. Temporal profile of TGF-b1 stimulation of IGFBP-3 release by
cortical fibroblasts. Confluent, quiescent cortical fibroblasts were incu-
bated in media containing TGF-b1 vehicle (control; E) or 1 ng/ml TGF-b1
(f). Media was collected at various time periods and assayed for
IGFBP-3. Results were adjusted for cellular protein content and were
significantly different between the two groups at each time period.
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human proximal tubule cells enhanced extracellular matrix
turnover by increasing both cortical fibroblast collagen
synthesis and matrix metalloproteinase (MMP) activity.
Dysregulation of MMP production has been observed in
several experimental models of renal disease, with early
increases in gelatinase expression, followed by suppression
in end-stage disease [15]. Enhanced MMP expression has
also been found to correlate with interstitial injury in
various human renal diseases, including diabetic nephrop-
athy [16] and IgA nephropathy [17]. Although there have
been no previous studies of tubulointerstitial paracrine
modulation of collagen synthesis, Lewis et al observed that
MMP-2 and MMP-9 production were decreased in cocul-
tures of rat PTC with cortical fibroblasts in the presence of
laminin, while apical MMP-2 and MMP-9 secretion were
stimulated when type IV collagen was used as the substrate
[6]. The latter results are qualitatively similar to those of
the present study, except that upregulation and activation
of gelatinases in tubulointerstitial coculture occurred exclu-
sively in the basolateral, rather than apical, compartment.
Our results therefore suggest a co-ordinated response of
the tubulointerstitium in cellular proliferation and matrix
remodeling via activation of MMPs [18, 19]. The final
balance between up-regulated MMP expression and en-
hanced collagen synthesis in tubulointerstitial coculture
may determine whether the net effect is a co-ordinated
repair of tissue or a progressive, fibrotic tubulointerstitial
obliteration.
Growth factors produced by PTC could function either
as sole activators of cortical fibroblasts in interstitial fibrosis
or in concert with growth factors produced by infiltrative
and resident interstitial cells. PDGF and TGF-b have each
been shown in vitro to stimulate many aspects of renal
fibrogenesis, including fibroblast proliferation, accumula-
tion of extracellular matrix, monocyte and fibroblast che-
motaxis, and vasoconstriction [20, 21]. Tubulointerstitial
Fig. 7. Immunoneutralization of cytokine
activity in PTC-CM. Thymidine incorporation
(f), collagen synthesis (M) and IGFBP-3
secretion (o) were measured in confluent
cortical fibroblasts incubated for 24 hours in
PTC-CM alone or in the presence of 30 mg/ml
anti-TGF-b (PTC-CM1anti-TGF-b), 30 mg/ml
mouse non-immune globulin (PTC-
CM1MNIG), 100 mg/ml anti-PDGF (PTC-
CM1anti-PDGF) or 100 mg/ml goat non-
immune globulin (PTC-CM1GNIG). Results
are normalized against control conditions
(cortical fibroblasts incubated in basic media).
anti-TGF-b and anti-PDGF had no effect on
basal levels of the parameters measured. *P ,
0.05 versus control. #P , 0.05 versus PTC-CM.
Fig. 8. Effects of transient acidification of PTC-CM on cortical fibro-
blasts. Confluent, quiescent cortical fibroblasts were incubated for 24
hours in PTC-CM either directly (f) or after transient acidification (TA
PTC-CM; M). Thymidine incorporation, collagen synthesis and IGFBP-3
release into media were then measured and expressed as percentages of
values obtained in appropriate controls (cortical fibroblasts incubated in
basic media or transiently acidified basic media).
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amplification of these responses may occur as a result of
TGF-b and PDGF autoinduction [20, 21] and mutual
stimulation of each other’s synthesis and biological activi-
ties [8, 21–24]. Evidence that TGF-b1 and PDGF-AB
contributed to the epithelial-stromal interactions found in
the current study was based on several observations: (i)
PTC constitutively secreted both cytokines; (ii) PTC secre-
tion of PDGF-AB was subject to reciprocal feedback by
cortical fibroblasts, possibly via an IGF-I/IGFBP paracrine
pathway; (iii) stimulation of cortical fibroblast thymidine
incorporation and IGFBP-3 production by PTC-CM was
reproduced by exogenous TGF-b1 and PDGF-AB; (iv)
PTC-stimulated cortical fibroblasts thymidine incorpora-
tion, collagen synthesis and IGFBP-3 production was in-
hibited by specific neutralizing antibodies directed against
TGF-b1 and PDGF-AB; and, (v) activation of latent,
endogenous TGF-b1 by transient acidification of PTC-CM
resulted in further potentiation of both cortical fibroblasts
collagen synthesis and IGFBP-3 production. Furthermore,
the absence of an additive effect from the combination of
anti-PDGF and anti-TGF-b antibodies in the mitogenic
assays implied that the two growth factors exerted their
actions via a common mechanism.
Several in vivo studies in human and experimental renal
disease suggest a central role of TGF-b and PDGF in
tubulointerstitial pathology. Renal cortical expression of
mRNAs for both cytokines and their receptors are up-
regulated in chronic cyclosporine toxicity [21, 25, 26],
diabetic nephropathy [21, 22, 27], the remnant kidney
model of chronic renal failure [28], chronic renal allograft
rejection [22, 29], and certain forms of glomerulonephritis
such as IgA nephropathy and lupus nephritis [21, 22, 30].
Infusion of angiotensin II into rats results in interstitial
fibrosis that is accompanied by overexpression of both
PDGF and TGF-b [21, 22]. Conversely, decreasing angio-
tensin II synthesis by angiotensin-converting enzyme inhib-
itors reduces TGF-b and PDGF overexpression, slows the
progression of human and experimental chronic renal
disease and significantly ameliorates tubulointerstitial his-
topathological changes in animal models [22]. More spe-
cific inhibition of tubulointerstitial TGF-b by administering
neutralizing anti-TGF-b antibodies to diabetic mice results
in reduced proximal tubular hypertrophy and substantial
attenuation of the interstitial overexpression of mRNAs
encoding type IV collagen and fibronectin [27]. Low pro-
tein diets also retard human and experimental interstitial
fibrosis [31, 32], and this has been linked to decreased
tubulointerstitial expression of TGF-b and PDGF [32, 33].
Despite this circumstantial evidence, the present study
provides a direct functional demonstration of activation of
cortical fibroblasts by PTC-derived TGF-b1 and PDGF-
AB. The juxtaposition of PTC releasing both of these
growth factors to adjacent cortical fibroblasts, which re-
spond in a specific fashion and exert feedback effects on
PTC cytokine production, strongly intimates the existence
of a paracrine system. Moreover, in the present study,
TGF-b1 enhanced the secretion of IGF-I and IGFBP-3 by
cortical fibroblasts, thereby recruiting additional paracrine
and autocrine growth factor pathways in human tubuloin-
terstitial interactions. IGFBP-3 production has also been
shown to be stimulated by TGF-b and by PDGF in human
skin fibroblasts [34–37], and in turn stimulates or inhibits
cell growth depending on the cell type, species and
experimental conditions [34, 38]. Indeed, studies in our
laboratory using IGF-I analogues with reduced affinity for
IGFBPs suggest that IGFBP-3 functions in the renal corti-
cal tubulointerstitium to enhance the actions of IGF-I on
PTC [7]. Thus, interstitial fibrosis is likely to occur on the
basis of tubular cell injury and aberrant activation of
multiple paracrine pathways, thereby culminating in pro-
gressive renal impairment through fibrotic destruction of
the renal parenchyma [2].
The results of the present experiments contrast with
those reported by Knecht et al in rabbit [3]. In that study,
papillary fibroblasts were stimulated by inner medullary
collecting duct epithelial cells via PDGF-AB cross-talk, but
no stimulation of cortical fibroblasts could be demonstrated
by PTC in coculture. Although the proliferative response of
rabbit cortical fibroblasts to exogenous PDGF-AB was
similar to that found by us in human cortical fibroblasts,
endogenous PDGF-AB could not be identified in rabbit
PTC-CM. Moreover, in contrast to the mitogenic response
of human fibroblasts to TGF-b demonstrated by us and by
other investigators [24], rabbit cortical fibroblasts prolifer-
ation was inhibited by TGF-b. The apparent disparity may
be explained by differences in experimental conditions,
given that the cells used by Knecht et al were studied at
subconfluence and following a higher number of initial
passages. Species-specific differences are also likely, since
media conditioned by rat PTC cultured on type IV collagen
stimulated rat cortical fibroblasts proliferation [6]. Further-
more, media conditioned by the African green monkey
kidney cell line (BSC-1) have been found to be mitogenic
for NRK fibroblasts, and this mitogenic effect is abrogated
by neutralizing anti-PDGF antibodies [39].
In conclusion, this study demonstrates that human prox-
imal tubule cells stimulate neighboring cortical fibroblasts
through paracrine mechanisms, which include the produc-
tion and release of PDGF-AB and TGF-b1. This paracrine
system is subject to reciprocal feedback regulation and
secondarily influences other cytokine networks, such as the
tubulointerstitial IGF-I/IGFBP axis. These results provide
compelling evidence that PTC modulate the biological
behavior of neighboring cortical fibroblasts in the human
kidney.
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APPENDIX
Abbreviations used in this article are: DMEM, Dulbecco’s modified
Eagle’s media; IGFBP, insulin-like growth factor binding protein; IGF-I
insulin-like growth factor-I; MMP, matrix matalloproteinase; NHE, sodi-
um-hydrogen exchange; PBS, phosphate buffered saline; PDGF, platelet-
derived growth factor; PDGF-AB, platelet-derived growth factor-AB
heterodimer; PTC, proximal tubule cells; PTC-CM, proximal tubule
cell-conditioned media; PTH, parathyroid hormone; RIA, radioimmuno-
assay; SDS, sodium dodecyl sulphate; TCA, trichloroacetic acid; TGF-b1,
transforming growth factor-b1.
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